CVD is the leading cause of death in the world. About eighteen million individuals worldwide die from the disease annually. Mortality rates vary considerably between countries; rates are lower in Japan and Mediterranean countries and highest in Eastern Europe (1) . Vascular function and reactivity is emerging as an important CVD risk factor and there is accumulating evidence to suggest that the amount and composition of fat in the diet is a major factor influencing endothelial cell function and vascular tone. Many studies have shown that dietary n-3 PUFA may have beneficial effects on vascular reactivity (2) . The endothelial NO synthase (eNOS) enzyme plays an important role in the regulation of vascular function, as it produces NO, which is an important vasodilator. However, the impact of longchain n-3 PUFA on eNOS activity remains poorly understood. The aim of the present in vitro study was to determine the impact of the long-chain n-3 PUFA EPA, docosapentaenoic acid (DPA) and DHA on NO production and eNOS regulatory pathways in human umbilical vein endothelial cells (HUVEC).
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HUVEC (70-90 % confluence) were incubated for 30 min, 4 h and 24 h with the individual fatty acids in BSA complex solution (2.5 :1, v/v) at 0-100 mM. Cytotoxicity effects were measured by Lactate Dehydrogenase (LDH) assay and MTT assay. The LDH was quantified using the CytoTOX-ONE TM Assay from Promega UK Ltd. The MTT assay was adapted (3) . eNOS phosphorylation and eNOS concentration were analysed by Westernblotting techniques with the appropriate antibody. All experiments were repeated at least in triplicate.
There was no significant toxic effect of any of fatty acid concentration in either the LDH assay or the MTT assay. The present study demonstrated that fish oil fatty acids (DHA, EPA and DPA) and Palmitic acid (0-100 mM for 30 min, 4 and 24 h) influenced eNOS phosphorylation and eNOS protein level in HUVEC. There was no significant effect on the ratio of eNOS phosphorylation and eNOS concentration for most of the fatty acids except with the 24 hr incubation time at 0, 1, 10 and 100 mM DHA (P £ 0.04) and with the 4 hr incubation at 25 and 100 mM PA (P£0.01). There was a trend toward increased eNOS phosphorylation to concentration ratio at 4 hrs in response to EPA with a dose effect evident but this did not reach significance (P > 0.05) (Figure 1 ). This result indicated that an increase in eNOS phosphorylation and eNOS protein level with EPA treatment may positively induce eNOS activity and NO production. In conclusion, there was little evidence of an effect of EPA, DPA or DHA on eNOS phosphorylation status in HUVEC cells, with evidence of a decrease following 24 h of exposure to DHA. 
